Skip to main content
Erschienen in: European Radiology 7/2023

18.01.2023 | Magnetic Resonance

Using T1 mapping indices to evaluate muscle function and predict conservative treatment outcomes in diabetic patients with peripheral arterial disease

verfasst von: Yu-Ching Lin, Tieh-Cheng Fu, Gigin Lin, Shu-Hang Ng, Chi-Hsiao Yeh, Soh-Chin Ng, Tsun-Ching Chang, Yu-Hsiang Juan

Erschienen in: European Radiology | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate interstitial muscle fibrosis via T1 mapping indices and its relationships with muscle function and conservative treatment outcomes.

Methods

A total of 49 DM patients with PAD were prospectively recruited from 2016 to 2017. All PAD patients underwent pre-treatment MRI with conservative treatment via a rehabilitation program and antiplatelet therapy. The need to require percutaneous transluminal angioplasty intervention was recorded as intolerance to conservative treatment outcomes. We quantified calf interstitial muscle fibrosis using T1 mapping indices (native T1, post-contrast T1, and the extracellular volume fraction [ECV]). Muscle function was evaluated using a 6-min walking test (6MWT) and a 3-min stepping test (3MST). PAD patients were divided into two groups according to their tolerance or intolerance of the conservative treatment. Pearson’s correlation, reproducibility, and multivariable Cox hazard analyses were performed with p < 0.05 indicating statistical significance.

Results

Among the T1 mapping indices in the posterior compartment of the calf in PAD patients, the native T1 value was significantly correlated with 6MWT (r =  −0.422, p = 0.010) and 3MST (r =  −0.427, p = 0.009). All T1 mapping indices showed excellent intra-observer and inter-observer correlations. ECV was an independent predictor of conservative treatment intolerance (average ECV, hazard ratio: 1.045, 95% confidence interval: 1.011–1.079, p = 0.009).

Conclusions

T1 mapping measurements are reproducible with excellent intra-observer and inter-observer correlations. T1 mapping indices may be predictive of treatment and functional outcomes and carry promise in patient evaluation.

Trial registration

Clinical Trials Identifier: NCT 02850432.

Key Points

• T1 mapping measurements of the calf muscles are reproducible with excellent intra-observer and inter-observer correlations (0.98 and 0.95 for anterior and posterior compartment muscle extracellular volume matrix [ECV] measurements, respectively).
• ECV is shown to independently predict conservative treatment intolerance.
• T1 mapping indices may be predictive of treatment and functional outcomes and carry promise in patient evaluation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ihnat DM, Mills JL Sr (2010) Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes. J Vasc Surg 52:92S-95SCrossRefPubMed Ihnat DM, Mills JL Sr (2010) Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes. J Vasc Surg 52:92S-95SCrossRefPubMed
2.
Zurück zum Zitat Forsythe RO, Brownrigg J, Hinchliffe RJ (2015) Peripheral arterial disease and revascularization of the diabetic foot. Diabetes Obes Metab 17:435–444CrossRefPubMed Forsythe RO, Brownrigg J, Hinchliffe RJ (2015) Peripheral arterial disease and revascularization of the diabetic foot. Diabetes Obes Metab 17:435–444CrossRefPubMed
3.
Zurück zum Zitat Mygind ND, Michelsen MM, Pena A et al (2016) Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study. J Cardiovasc Magn Reson 18:76CrossRefPubMedPubMedCentral Mygind ND, Michelsen MM, Pena A et al (2016) Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study. J Cardiovasc Magn Reson 18:76CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Ng AC, Auger D, Delgado V et al (2012) Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T(1) mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study. Circ Cardiovasc Imaging 5:51–59CrossRefPubMed Ng AC, Auger D, Delgado V et al (2012) Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T(1) mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study. Circ Cardiovasc Imaging 5:51–59CrossRefPubMed
5.
Zurück zum Zitat Sfyri P, Matsakas A (2017) Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease. J Biomed Sci 24:42CrossRefPubMedPubMedCentral Sfyri P, Matsakas A (2017) Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease. J Biomed Sci 24:42CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Ha DM, Carpenter LC, Koutakis P et al (2016) Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease. J Transl Med 14:39CrossRefPubMedPubMedCentral Ha DM, Carpenter LC, Koutakis P et al (2016) Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease. J Transl Med 14:39CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Piechnik SK, Ferreira VM, Dall'Armellina E et al (2010) Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 12:69 Piechnik SK, Ferreira VM, Dall'Armellina E et al (2010) Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 12:69
8.
Zurück zum Zitat Flett AS, Hayward MP, Ashworth MT et al (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122:138–144CrossRefPubMed Flett AS, Hayward MP, Ashworth MT et al (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122:138–144CrossRefPubMed
9.
Zurück zum Zitat Wong TC, Piehler K, Meier CG et al (2012) Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 126:1206–1216CrossRefPubMedPubMedCentral Wong TC, Piehler K, Meier CG et al (2012) Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 126:1206–1216CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Lin YC, Chuang WY, Wei FC et al (2020) Peripheral arterial disease: the role of extracellular volume measurements in lower limb muscles with MRI. Eur Radiol 30:3943–3950CrossRefPubMed Lin YC, Chuang WY, Wei FC et al (2020) Peripheral arterial disease: the role of extracellular volume measurements in lower limb muscles with MRI. Eur Radiol 30:3943–3950CrossRefPubMed
11.
Zurück zum Zitat Aboyans V, Ricco JB, Bartelink MEL et al (2018) 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39:763–816CrossRefPubMed Aboyans V, Ricco JB, Bartelink MEL et al (2018) 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39:763–816CrossRefPubMed
12.
Zurück zum Zitat ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111-117 ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111-117
13.
Zurück zum Zitat Golding LA (2000) YMCA fitness testing and assessment manual, 4th edn. Human Kinetics Publishers, Champaign (IL) USA Golding LA (2000) YMCA fitness testing and assessment manual, 4th edn. Human Kinetics Publishers, Champaign (IL) USA
14.
Zurück zum Zitat Kellman P, Wilson JR, Xue H, Ugander M, Arai AE (2012) Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson 14:63CrossRefPubMedPubMedCentral Kellman P, Wilson JR, Xue H, Ugander M, Arai AE (2012) Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson 14:63CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Hothorn TaL B (2003) On the exact distribution of maximally selected rank statistics. Comput Stat Data Anal 43:121–137CrossRef Hothorn TaL B (2003) On the exact distribution of maximally selected rank statistics. Comput Stat Data Anal 43:121–137CrossRef
17.
Zurück zum Zitat Kropielnicka K, Dziubek W, Bulinska K et al (2018) Influence of the physical training on muscle function and walking distance in symptomatic peripheral arterial disease in elderly. Biomed Res Int 2018:1937527CrossRefPubMedPubMedCentral Kropielnicka K, Dziubek W, Bulinska K et al (2018) Influence of the physical training on muscle function and walking distance in symptomatic peripheral arterial disease in elderly. Biomed Res Int 2018:1937527CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Nguyen LL (2007) Percutaneous treatment of peripheral vascular disease: the role of diabetes and inflammation. J Vasc Surg 45 Suppl A:A149–157 Nguyen LL (2007) Percutaneous treatment of peripheral vascular disease: the role of diabetes and inflammation. J Vasc Surg 45 Suppl A:A149–157
19.
Zurück zum Zitat Noronen K, Saarinen E, Alback A, Venermo M (2017) Analysis of the elective treatment process for critical limb ischaemia with tissue loss: diabetic patients require rapid revascularisation. Eur J Vasc Endovasc Surg 53:206–213CrossRefPubMed Noronen K, Saarinen E, Alback A, Venermo M (2017) Analysis of the elective treatment process for critical limb ischaemia with tissue loss: diabetic patients require rapid revascularisation. Eur J Vasc Endovasc Surg 53:206–213CrossRefPubMed
20.
Zurück zum Zitat Xiao L, Huang DS, Tong JJ, Shen J (2012) Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease: a retrospective trial. Cardiovasc Diabetol 11:17CrossRefPubMedPubMedCentral Xiao L, Huang DS, Tong JJ, Shen J (2012) Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease: a retrospective trial. Cardiovasc Diabetol 11:17CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Foley TR, Waldo SW, Armstrong EJ (2016) Antithrombotic therapy in peripheral artery disease. Vasc Med 21:156–169CrossRefPubMed Foley TR, Waldo SW, Armstrong EJ (2016) Antithrombotic therapy in peripheral artery disease. Vasc Med 21:156–169CrossRefPubMed
22.
Zurück zum Zitat Puntmann VO, Carr-White G, Jabbour A et al (2016) T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovasc Imaging 9:40–50CrossRefPubMed Puntmann VO, Carr-White G, Jabbour A et al (2016) T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovasc Imaging 9:40–50CrossRefPubMed
Metadaten
Titel
Using T1 mapping indices to evaluate muscle function and predict conservative treatment outcomes in diabetic patients with peripheral arterial disease
verfasst von
Yu-Ching Lin
Tieh-Cheng Fu
Gigin Lin
Shu-Hang Ng
Chi-Hsiao Yeh
Soh-Chin Ng
Tsun-Ching Chang
Yu-Hsiang Juan
Publikationsdatum
18.01.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 7/2023
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-023-09392-8

Weitere Artikel der Ausgabe 7/2023

European Radiology 7/2023 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.